Banimmo SA
LSE:0NG8
Banimmo SA
LSE:0NG8
Price:
2.96
EUR
-17.32%
Market Closed
Market Cap:
€33.3m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Banimmo SA
LSE:0NG8
|
BE |
|
P
|
Pasifik Gayrimenkul Yatirim Ortakligi AS
IST:PSGYO.E
|
TR |
|
Genesco Inc
NYSE:GCO
|
US |
|
C
|
Curbline Properties Corp.
NYSE:CURB
|
US |
|
Astria Therapeutics Inc
NASDAQ:ATXS
|
US |
|
N
|
Nikki Co Ltd
TSE:6042
|
JP |
|
S
|
Samchem Holdings Bhd
KLSE:SAMCHEM
|
MY |
|
Squarespace Inc
NYSE:SQSP
|
US |
|
Styland Holdings Ltd
HKEX:211
|
HK |
Income Statement
Earnings Waterfall
Banimmo SA
Banimmo SA
Income Statement
Banimmo SA
Banimmo SA
Currency: EUR
| Dec-2018 | Jun-2019 | Dec-2019 | Jun-2020 | Dec-2020 | Jun-2021 | Dec-2021 | Jun-2022 | Dec-2022 | Jun-2023 | Dec-2023 | Jun-2024 | Dec-2024 | Jun-2025 | Dec-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | ||||||||||||||||
| Interest Expense |
5
|
0
|
3
|
0
|
3
|
0
|
4
|
0
|
3
|
0
|
3
|
0
|
0
|
0
|
0
|
|
| Revenue |
55
N/A
|
5
-91%
|
4
-15%
|
4
+1%
|
3
-23%
|
3
-11%
|
81
+2 677%
|
82
+1%
|
5
-94%
|
5
+10%
|
6
+9%
|
7
+17%
|
7
+8%
|
7
+1%
|
7
+1%
|
|
| Gross Profit | ||||||||||||||||
| Cost of Revenue |
(50)
|
(3)
|
(1)
|
(1)
|
(1)
|
(6)
|
(64)
|
(66)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
|
| Gross Profit |
5
N/A
|
2
-53%
|
3
+38%
|
3
-6%
|
3
-8%
|
(3)
N/A
|
17
N/A
|
15
-8%
|
4
-74%
|
4
+7%
|
5
+14%
|
6
+14%
|
7
+18%
|
7
+1%
|
7
+1%
|
|
| Operating Income | ||||||||||||||||
| Operating Expenses |
(7)
|
(6)
|
(4)
|
(2)
|
(1)
|
8
|
4
|
2
|
(5)
|
(4)
|
(8)
|
(7)
|
(3)
|
(3)
|
(3)
|
|
| Selling, General & Administrative |
(5)
|
(5)
|
(4)
|
(3)
|
(3)
|
(3)
|
(4)
|
(3)
|
(3)
|
(4)
|
(5)
|
(4)
|
(4)
|
(5)
|
(4)
|
|
| Research & Development |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Depreciation & Amortization |
(0)
|
(0)
|
(1)
|
(0)
|
(1)
|
(0)
|
(1)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
|
| Other Operating Expenses |
(2)
|
(1)
|
1
|
2
|
2
|
12
|
8
|
6
|
(1)
|
(0)
|
(3)
|
(3)
|
2
|
2
|
2
|
|
| Operating Income |
(2)
N/A
|
(3)
-84%
|
(1)
+79%
|
1
N/A
|
2
+85%
|
6
+249%
|
21
+278%
|
17
-16%
|
(0)
N/A
|
(0)
+78%
|
(3)
-2 664%
|
(2)
+38%
|
4
N/A
|
4
-4%
|
4
-1%
|
|
| Pre-Tax Income | ||||||||||||||||
| Interest Income Expense |
(3)
|
(5)
|
(4)
|
(5)
|
(2)
|
(1)
|
8
|
12
|
3
|
(1)
|
(4)
|
(2)
|
(1)
|
(5)
|
(4)
|
|
| Non-Reccuring Items |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Other Income |
0
|
(0)
|
0
|
1
|
(0)
|
(1)
|
(0)
|
(0)
|
(0)
|
(0)
|
0
|
(0)
|
(1)
|
(0)
|
0
|
|
| Pre-Tax Income |
(4)
N/A
|
(9)
-112%
|
(4)
+57%
|
(3)
+31%
|
(1)
+59%
|
4
N/A
|
28
+603%
|
30
+5%
|
2
-92%
|
(2)
N/A
|
(6)
-253%
|
(4)
+35%
|
3
N/A
|
(2)
N/A
|
0
N/A
|
|
| Net Income | ||||||||||||||||
| Tax Provision |
(2)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(2)
|
(2)
|
(1)
|
(1)
|
0
|
0
|
0
|
0
|
(0)
|
|
| Income from Continuing Operations |
(6)
|
(10)
|
(4)
|
(3)
|
(1)
|
4
|
27
|
28
|
2
|
(3)
|
(6)
|
(4)
|
3
|
(2)
|
0
|
|
| Income to Minority Interest |
0
|
0
|
0
|
0
|
(0)
|
(0)
|
0
|
0
|
0
|
0
|
0
|
(1)
|
(1)
|
0
|
1
|
|
| Net Income (Common) |
(5)
N/A
|
(9)
-56%
|
(3)
+68%
|
(2)
+35%
|
(2)
+7%
|
3
N/A
|
25
+622%
|
26
+6%
|
3
-87%
|
(1)
N/A
|
(6)
-658%
|
(5)
+27%
|
2
N/A
|
(1)
N/A
|
1
N/A
|
|
| EPS (Diluted) |
-0.48
N/A
|
-0.76
-58%
|
-0.24
+68%
|
-0.15
+38%
|
-0.14
+7%
|
0.3
N/A
|
2.22
+640%
|
2.34
+5%
|
0.29
-88%
|
-0.07
N/A
|
-0.57
-714%
|
-0.41
+28%
|
0.21
N/A
|
-0.12
N/A
|
0.07
N/A
|
|
Switch to:
Switch to:
See Also
Discover More
